Multiples are still healthy, but the long run of rising prices may be ending. Buyers are now paying the premium for well-run firms that depend little on their owner.
General information for practice owners, current at the time of writing (July 2026). Figures are as reported by industry sources; rules and deadlines change — check the current position and take your own advice.
For several years UK accountancy M&A prices rose steadily. Private-equity-backed consolidation pushed valuations well above the levels of a decade ago, and reportedly almost half of the top-60 UK firms now have some level of PE involvement. In 2026 the picture is changing, and that affects any owner thinking about selling.
| Deal type | Commonly reported |
|---|---|
| General practice, recurring-fee multiple | ~1.0–1.2× GRF |
| High-quality blocks of fees | talk of 1.4–1.5× |
| Larger, PE-relevant deals (EBITDA) | ~4–7× |
Those are still healthy numbers. Data from early 2026 suggests headline valuations have hit a ceiling, and buyers are checking growth assumptions far more closely than they were. Investors who paid for scale are becoming more selective.
As the market cools, the quality of the firm has a larger effect on price. In a rising market an average firm could still sell well. In a flat or cooling market, a well-organised practice with low owner-dependency can achieve a strong sale while an owner-dependent one is discounted. Owners can improve these things before a sale; see how to increase value before you sell and what reduces it.
A high headline multiple is worth less if the deal is loaded with contingent consideration and clients leave during the buyer's “optimisation” phase. In a cooling market, the choice of buyer and the structure of the deal matter as much as the number. Our article on roll-ups vs selling direct covers this in more detail, and a realistic valuation is the place to start.
Data from early 2026 suggests headline valuations have hit a ceiling after years of private-equity-fuelled rises, with buyers scrutinising aggressive multiples more closely. Multiples remain healthy, and buyers are paying the premium mainly for high-quality firms.
General practice commonly trades around 1.0–1.2× gross recurring fees, with high-quality blocks attracting talk of 1.4–1.5×, and larger PE-style deals framed at roughly 4–7× EBITDA. Figures are as reported and vary by quality.
If your firm is strong, selling now is generally a better option than waiting for a rebound that may not come. The right timing is still personal and depends on your energy, plans and firm quality. Quality now matters more to buyers, so lifting value first can pay off.
In a rising market even average firms sold well. As the market flattens, buyers pay a premium for low owner-dependency, strong recurring income and clean systems, and discount weaker books more heavily. The gap between good and average firms is therefore widening.

Book a confidential call with the buyer to discuss what your practice might be worth now, and whether to sell, wait or step back gradually.
Book a confidential call
Andy Jackson, co-founder